New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Immuneering Corporation
IMRX
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

60M

Biotechnology

Next Earning date - 14 Nov 2024

60M

Biotechnology

Next Earning date - 14 Nov 2024

2.01USD
Shape-0.14 ( -6.51%)
favorite-chart

Relative Strenght

2
favorite-chart

Volume Buzz

-94%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

77%

Quote Panel

Shape
Updated October 28, 2024
1W -8.64 % 1M -19.28 % 3M 57.03 % 1Y -66.28 %

Key Metrics

Shape
  • Market Cap

    59.60M


  • Shares Outstanding

    29.65M


  • Share in Float

    21.00M


  • Dividende

    0


  • Earning Date

    14 Nov 2024


  • Price Target

    2.01


  • Average Volume

    6.79M


  • Beta

    -0.453


  • Range

    1.0-8.89


  • Industry

    Biotechnology


  • Website

    https://immuneering.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

Nanx

P/S Ratio

0.90x

P/B Ratio

0.1

Debt/Equity

59.4%

Net Margin

$-1.9

EPS

How IMRX compares to sector?

P/E Ratio

Relative Strength

Shape

IMRX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$1M

ShapeNaN%

2025-Revenue

$1.71

Shape-263%

2025-EPS

$653K

Shape96%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Mizuho Securities

upgrade

Previous: Not converted

2023-04-19

Now: Buy

Chardan Capital

initialise

Previous: Not converted

2022-07-09

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.49
vs -0.47

Q4.22

arrow
arrow

N/A

-0.50
vs -0.42

Q1.23

arrow
arrow

N/A

-0.51
vs -0.49

Q2.23

arrow
arrow

N/A

-0.43
vs -0.44

Q3.23

arrow
arrow

N/A

-0.43
vs -0.49

Q4.23

arrow
arrow

N/A

-0.52
vs -0.50

Q1.24

arrow
arrow

N/A

-0.49
vs -0.51

Q2.24

arrow
arrow

N/A

-0.47
vs -0.43

Q3.24

arrow
arrow

N/A

-0.55
vs -0.43

Q4.24

arrow
arrow

N/A

-0.43
vs -0.52

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

-75%

183.7K  vs 748.2K

Q2.22

arrow
arrow

-86%

94.4K  vs 660K

Q3.22

arrow
arrow

-92%

38.4K  vs 482.1K

Q4.22

arrow
arrow

-100%

456  vs 189.6K

Q1.23

arrow
arrow

-100%

NA  vs 183.7K

Q2.23

arrow
arrow

+99900%

94.4M  vs 94.4K

Q3.23

arrow
arrow

-100%

NA  vs 38.4K

Q4.23

arrow
arrow

-20706021%

-94419000.00  vs 456

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

-100%

NA  vs 94.4M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-10%

-0.10
vs -0.09

Q4.22

arrow
arrow

-11%

-0.11
vs -0.10

Q1.23

arrow
arrow

+1086%

10.86
vs -0.11

Q2.23

arrow
arrow

-11%

-0.11
vs 10.86

Q3.23

arrow
arrow

-12%

-0.12
vs -0.11

Q4.23

arrow
arrow

-17%

-0.17
vs -0.12

Q1.24

arrow
arrow

-18%

-0.18
vs -0.17

Q2.24

arrow
arrow

-21%

-0.21
vs -0.18

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

32

32
vs 33

-3%

Q4.22

arrow
arrow

32

32
vs 32

NA

Q1.23

arrow
arrow

34

34
vs 32

6%

Q2.23

arrow
arrow

49

49
vs 34

44%

Q3.23

arrow
arrow

53

53
vs 49

8%

Q4.23

arrow
arrow

52

52
vs 53

-2%

Q1.24

arrow
arrow

50

50
vs 52

-4%

Q2.24

arrow
arrow

55

55
vs 50

10%

Earnings Growth

Latest News